Seven years of qualification
Audited Supplier
In This Store
One leading biotechnology provider of CDMO/CMO in biofermenation, bioconversion,synthesis and biomanufacturing of APIs, cosmeceuticals, nutraceuticals and enzymes.
Year of Establishment: 2011
Total Assets(USD): More than 99,999,999
Total Number of Staff: 50-100
Main Competitive Advantages: Experienced R&D Staff,Contract Manufacturing (CRO,CMO)
Other Competitive Advantages: 1, Market oriented and biotechnology driven BioHub 2, Team of Scientist, Technician and Engineer 3, BioLab-BioFab of one stop upscaling. 4, Disccovery to AIs and to FDFs. 5, Experience with 100+ projects
Patents and Copyrights: many patents and technical know-hows related with strains, enzymes and technologies.
Contact Us
Tel: (+86) 400 610 1188
WhatsApp/Telegram/Wechat: +86 13621645194
Follow Us：
Pharma Sources Insight June 2024: Globalization on the Go
